Search results
Results from the WOW.Com Content Network
The capsule biosynthesis, or CPS operon, is a section of the genome present in some Escherichia coli, of which regulates the production of polysaccharides making up the bacterial capsule. [1] These polysaccharides help protect the bacteria from harsh environments, toxic chemicals, and bacteriophages .
Cell-surface polysaccharides play diverse roles in bacterial ecology and physiology. They serve as a barrier between the cell wall and the environment, mediate host-pathogen interactions. Polysaccharides also play an important role in formation of biofilms and the structuring of complex life forms in bacteria like Myxococcus xanthus [5].
NmVac4-A/C/Y/W-135 is the commercial name for a polysaccharide vaccine that protects against meningococcal meningitis caused by Neisseria meningitidis, specifically the serotypes A, C, Y, and W-135. This vaccine is part of a broader group of meningococcal vaccines .
Polysaccharide A (PSA) is a polysaccharide produced by the Gram-negative bacterium Bacteroides fragilis. [1] B.fragilis produces eight identified distinct capsular polysaccharides, identified by the letters "A" through "H". [2] PSA colonization of B. fragilis in the gut mucosa induces regulatory T cells and suppresses pro-inflammatory T helper ...
Some types of H. influenzae contain a polysaccharide capsule around the outer membrane to aid in protection and colonization. [14] The bacteria are pleomorphic, meaning the shape of the bacterium is variable, however it is typically coccobacillus or rod-shaped. [15] H. Influenzae contains pili, which are specialized to adhere to the human ...
The pneumococcal polysaccharide vaccine is widely used in high-risk adults. [4] First used in 1945, the tetravalent vaccine was not widely distributed, since its deployment coincided with the discovery of penicillin. [5] In the 1970s, Robert Austrian championed the manufacture and distribution of a 14-valent pneumococcal polysaccharide vaccine.
The capsule can protect cells from engulfment by eukaryotic cells, such as macrophages. [7] A capsule-specific antibody may be required for phagocytosis to occur. They also exclude bacterial viruses and most hydrophobic toxic materials such as detergents. [citation needed] Immunity to one capsule type does not result in immunity to the other ...
[1] [2] [3] Several types are widely available: typhoid conjugate vaccine (TCV), Ty21a (a live oral vaccine) and Vi capsular polysaccharide vaccine (ViPS) (an injectable subunit vaccine). They are about 30 to 70% effective in the first two years, depending on the specific vaccine in question. The Vi-rEPA vaccine is efficacious in children. [4]